Work

A Phase II of Combination D aunorubicin and Cytarabine (A ra-c) and Nilotinib (TA signa) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression: Interim Results

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.3808.3808

Authors: Aref Al-Kali, Raoul Tibes, Jeanne Palmer, Hassan B Alkhateeb, Pamela Atherton, Fei Yan, Shujun Liu, Rong He, Shahrukh K. Hashmi, Mark R Litzow

Institutions: Mayo Clinic, Mayo Clinic in Arizona, University of Minnesota

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2586788687

FWCI:

Cites:

Cited by:

Related to: 10